VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 780 · 108th Congress

Prescription Drug Price Reduction Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

Prescription Drug Price Reduction Act - Amends the Federal Food, Drug, and Cosmetic Act to repeal the condition on the permission to pharmacists and wholesalers to import prescription drugs from Canada into the United States that the Secretary first demonstrate to Congress the safety of such products and the financial benefit to consumers of permitting…

What it does: CRS summary · Introduced in House · Feb 13, 2003
Prescription Drug Price Reduction Act - Amends the Federal Food, Drug, and Cosmetic Act to repeal the condition on the permission to pharmacists and wholesalers to import prescription drugs from Canada into the United States that the Secretary first demonstrate to Congress the safety of such products and the financial benefit to consumers of permitting their importation. (Thus allows the importation of such drugs to proceed without fulfillment of prerequisites.) Repeals termination of the importation program.

Directs the Secretary to promulgate a final rule for carrying out the provisions on covered products within a year of the enactment of this Act, with the effective date for such final rule to be no later than 30 days after the date of promulgation.

Classifies an imported covered product as misbranded unless it bears labeling that identifies: (1) the country of origin; (2) the name and address of the importer; and (3) the name and address of the person who exported the product to the United States.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Prescription Drug Price Reduction Act

Latest action (Feb 26, 2003): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Feb 13, 2003

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.